Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


The ABC of Enterprise

16 December 2014

What is UCL Enterprise and how can we help you?
Learn how UCL Enterprise can support your professional development and help you demonstrate impact within your research.

The ABC of Enterprise is a 30-minute introduction to what resources, services, activities, funding and support UCL Enterprise can offer UCL academics and their students.

  • UCL Enterprise Operations
  • Corporate and Industrial Partnerships
  • UCL Advances
  • UCL Business
  • UCL Consultants

To invite UCL Enterprise to one of your departmental meetings or to obtain further information please e-mail enterprise@ucl.ac.uk with the subject line: The ABC of Enterprise